250-323 exam Dumps Source : Data Protection Administration for(R) Windows using NBU 5.0
Test Code : 250-323
Test denomination : Data Protection Administration for(R) Windows using NBU 5.0
Vendor denomination : Symantec
real questions : 201 actual Questions
What are middle objectives state-of-the-art 250-323 exam?
When I was getting prepared up for my 250-323 , It was very annoying to select the 250-323 study material. I organize killexams.com while googling the best certification resources. I subscribed and saw the wealth of resources on it and used it to prepare for my 250-323 test. I transparent it and Im so grateful to this killexams.com.
Get %. ultra-modern information to prepare 250-323 exam. first-rate actual questions
i used to live now not equipped to recognize the points nicely. in any case resulting from my partner killexams.com Questions & solutions who bailed me to depart this trepidation by fitting questions and answers to allude; I efficaciously endeavored 87 questions in eighty minutes and passed it. killexams.com in fact turned out to live my actual associate. As and when the exam dates of 250-323 occupy been forthcoming nearer, i used to live getting to live anxious and apprehensive. a considerable deal appreciated killexams.com.
Just read these Latest dumps and success is yours.
I am jubilant to uncover that I occupy successfully passed the 250-323 Exam. In this context I requisite to admit that your Question Bank did palliate (if now not fully) to tied over the exam because the questions asked in the exam had been now not absolutely blanketed with the aid of your questions bank. HOwever I requisite to congratulate your attempt to execute us technically sound together with your actual questions s. Thanks to killexams.com for clearing my 250-323 exam in first elegance.
strive out these actual 250-323 brand newmodern dumps.
I passed this exam with killexams.com and occupy recently obtained my 250-323 certificate. I did totality my certifications with killexams.com, so I cant compare what its enjoy to recall an exam with/without it. Yet, the fact that I preserve coming back for their bundles shows that Im jubilant with this exam solution. I carefor being able to exercise on my computer, in the solace of my home, especially when the vast majority of the questions appearing on the exam are exactly the same what you saw in your exam simulator at home. Thanks to killexams.com, I got up to the Professional level. I am not positive whether Ill live lamentable up any time soon, as I appear to live jubilant where I am. Thanks Killexams.
of time on internet! located genuine source of 250-323 questions.
Preparation package has been very advantageous in the course of my exam training. I got 100% im now not an first rate test taker and might skip spotless on the exam, which isnt a brilliant thing, especially if that is 250-323 exam, while time is your enemy. I had revel in of failing IT tests in the past and wanted to preserve away from it at totality prices, so i bought this package deal deal. It has helped me pass with 100%. It had the entirety I had to realize, and for the understanding that I had spent countless hours analyzing, cramming and making notes, I had no problem passing this exam with the very excellent marks viable.
You just requisite
a weekend for 250-323 exam prep with these dumps.
Can you smell the sweet fragrance of triumph I know I can and it is actually a very elegant odor. You can smell it too if you log on to this killexams.com in order to prepare for your 250-323 test. I did the same thing prerogative before my test and was very satisfied with the service provided to me. The facilities here are impeccable and once you are in it you wouldnt live worried about failing at all. I didnt fail and did quite well and so can you. Try it!
discovered an genuine source for actual 250-323 exam questions.
i would clearly recommend killexams.com to each person whos giving 250-323 exam as this now not just helps to graze up the concepts inside the workbook but additionally gives a fantastic concept about the sample of questions. first rate palliate ..for the 250-323 exam. thank you a lot killexams.com crew !
Tips & tricks to certify 250-323 exam with towering scores.
I used to live very dissatisfied once I failed my 250-323 exam. Searching the internet told me that there can live a website killexams.com thats the belongings that I requisite to pass the 250-323 exam within no time. I purchase the 250-323 steering percent.Containing questions answers and exam simulator, organized and recall a seat inside the exam and gotninety 8% marks. Thanks to the killexams.com team.
Real 250-323 questions and brain dumps! It warrant
We requisite to discover ways to select their brain simply the identical manner, they pick out out their garments everyday. This is the energy they are able to habitat.Having stated that If they requisite to Do matters in their life, they should war difficult to recognize totality its powers. I did so and worked tough on killexams.com to find out high-quality position in 250-323 exam with the assist of killexams.com that proved very energetic and extraordinary application to discover desired feature in 250-323 exam.It changed into a super application to execute my being relaxed.
Where should I search to accumulate 250-323 actual test questions?
To accumulate success in 250-323 exam. Humans accord with that a student occupy to possess sharp brain. Although its miles genuine but it isnt entirely upright on account that in conjunction with the pupil, the instruct or the teacher requisite to likewise live rightly certified and knowledgeable. I undergo blessed that I was acquainted with this killexams.com in which I met such awesome educators who taught me a artery to transparent my 250-323 test and were given me through them with a breeze. I thank them with the lowest of my coronary heart.
Title: C-stage/President manager VP team of workers (affiliate/Analyst/and many others.) Directorcharacteristic:
role in IT decision-making system: Align company & IT goals Create IT routine assess IT wants control seller Relationships evaluate/Specify brands or companies different role empower Purchases now not worriedWork cell: business: business measurement: industry: highway address city: Zip/postal code State/Province: country:
on occasion, they dispatch subscribers special offers from opt for partners. Would you enjoy to receive these special partner presents by means of e-mail? yes No
Your registration with Eweek will encompass here free e-mail newsletter(s): tidings & Views
by artery of submitting your wireless quantity, you settle that eWEEK, its related homes, and vendor companions proposing content you view may contact you the exhaust of contact seat technology. Your consent isn't required to view content or exhaust website features.
Registercontinue devoid of consent
MOUNTAIN VIEW, Calif.--(enterprise WIRE)--Symantec Corp. (NASDAQ: SYMC), the area’s leading cyber security business, these days introduced that greater than 120 agencies occupy joined forces with Symantec to force down the can imbue and complexity of cyber safety, whereas improving response times to protect companies against subtle threats. This includes primary avid gamers enjoy AWS, box, IBM safety, Microsoft, Oracle, ServiceNow and Splunk, in addition to dozens of different technology innovators, who are now pile or offering more than 250 products and capabilities that combine with Symantec’s built-in Cyber defense (ICD) Platform.
“The probability landscape totality of us face isn't static and is continually on the flow, as are their customers and personnel, so techniques to deal with that variety of ambiance are very complicated”Tweet this
This remarkable business collaboration reflects a “platform shift” in the cyber security trade, as unusual analysis from enterprise approach community (ESG) indicates enterprise consumers want to consolidate providers and undertake more integrated structures backed with the aid of an open ecosystem.
built-in defense improves security by means of expanding the velocity and effectiveness, whereas drastically decreasing the supplies required. To execute that shift even simpler, Symantec likewise nowadays introduced vital innovations – together with a unusual widely wide-spread statistics exchange, shared administration capabilities, and upgraded information loss prevention utility that support purchasers discontinue untrusted apps before they compromise exclusive information. totality are built on Symantec’s ICD Platform, which provides a unified framework for assistance protection, risk insurance policy, identity administration and compliance across endpoints, networks, purposes, and clouds.
“There’s a seismic shift going on in cyber protection,” observed artwork Gilliland, EVP and GM business items, Symantec. “The ancient means of combating cyber-attacks the exhaust of fragmented tools has spin into too complicated and costly to control. built-in structures are the long run. We’re disdainful to live main this platform shift with a transparent vision and successful portfolio – along with a whole bunch of companions and thousands of experts working each day on the entrance traces to give protection to their customers. we're completely convinced that their finest protection going ahead is an integrated protection.”
New analysis Demonstrates the requisite for integrated structures
ESG currently published unusual client research showcasing how the inability of a cohesive safety technology strategy creates actual issues for companies, leading clients to are seeking greater integrated systems and fewer, extra strategic vendors. Key findings in line with the analysis consist of:
“practically two-thirds of big firms surveyed exhaust as a minimum 25 distinctive cyber security products. For safety operations facilities, managing disparate materiel can live ineffective, costly, and time drinking, above totality considering the fact that the shortage of cyber security talents,” talked about Jon Oltsik, senior predominant analyst and fellow, ESG. “This explains why CISOs wish to consolidate and integrate their security infrastructure with systems and open architectures that provide superior developer support and convey a accomplice ecosystem with potent third-birthday party integrations.”
Symantec Integrates items, functions and companions
Symantec began constructing ICD two and a half years in the past with its acquisition of Blue Coat systems, which introduced most effective-of-breed net and cloud safety applied sciences to Symantec’s market-main endpoint, email and data loss prevention (DLP) technologies. at the time, Symantec saw and heard that purchasers occupy been spending gigantic time and supplies to integrate factor applied sciences with a purpose to derive actual cost from their cyber security investments. So, the enterprise invested in a methodology and roadmap to bring an integrated platform that greatly reduces can imbue of operations whereas enhancing the velocity and accuracy of prevention, detection and response in an pains to reduce back risk.
since then, Symantec has:
ICD Platform Earns vast Ecosystem guide
Symantec now has greater than a hundred and twenty partners in TIPP, who're pile or providing greater than 250 unusual purposes and features that combine with Symantec’s ICD Platform, so commercial enterprise customers can reduce the imbue and complexity of their protection operations. in addition, Symantec is now launching a unusual “Innovation Playground” software within TIPP to simplify integration with startups. the brand unusual program will enable startup groups to leverage Symantec APIs and gain access to items, engineering substances, and customer innovation days.
“as a artery to reduce back safety operations complexity and combat today’s more and more refined adversary, groups want products that work as a platform as an alternative of a military of point items working in silos,” referred to Oliver Friedrichs, VP of safety automation and orchestration at Splunk. “Splunk’s aid for the ICD Platform gives their joint clients with consolidated views throughout their protection infrastructure, including incidents flowing from endpoint, web, network and electronic mail security options.”
“At box, safety is a precise priority and they are committed to providing their purchasers with effective controls to give protection to their sensitive content material,” talked about Niall Wall, senior vice chairman of partners at field. “Symantec is a founding member of the domain faith Ecosystem. we're excited about Symantec’s built-in Cyber defense and the artery it's going to support our mutual purchasers in the reduction of risk of statistics loss, notice advanced threats, and seamlessly collect their protection capabilities.”
“safety analysts these days cope with increasingly tangled threats, fragmented safety equipment, and siloed businesses,” said wealthy Telljohann, director of enterprise pile at IBM safety. “To combat this they are since the cyber protection landscape is disturbing a shift to integrated platforms with a view to reduce complexity and value. we now occupy constructed an integration using Symantec ICD change, so the IBM Resilient Incident Response Platform can provide ingenious orchestration, automation, and enrichment of incidents prompted with the aid of Symantec ICD, allowing analysts to respond intelligently to threats.”
ICD Platform Drives customer Adoption and cost
As evidenced by Symantec’s fresh quarterly salary, further and further consumers are relocating past individual items to undertake the ICD platform and portfolio. as an instance:
“The hazard panorama they totality face is not static and is at totality times on the flow, as are their consumers and employees, so ideas to cope with that sort of environment are very complicated,” spoke of Emily Heath, vice president and chief tips safety officer, United airlines. “Visibility of your atmosphere and integration of solutions are a key a portion of that method. as an example, if one security handle catches something, it is an dreadful lot greater productive for us if those controls are built-in and may discourse seamlessly with each other to palliate with actual time detection. additionally, if security suppliers recall the time to integrate throughout the stack so they don’t should, that results in an excellent better influence.”
Symantec Extends ICD Platform with unusual facets & features
Symantec is introducing three unusual know-how improvements these days that prolong ICD for shared intelligence and shared administration across multiple technology add-ons, in addition to unusual “possibility mindful” data coverage capabilities:
For more counsel on ICD, gratify talk over with: www.symantec.com/icd.
For more details about TIPP, gratify hunt recommendation from: https://www.symantec.com/expertise-partners.
For greater details on how Symantec and companions are leading the shift to integrated Cyber protection, gratify consult with: https://www.symantec.com/blogs/function-experiences/united-we-stand
For extra details on the cyber safety platform shift, gratify visit: https://www.symantec.com/blogs/feature-reviews/cyber-security-platform-shift-more-at ease-less-complicated
to notice a detailed mapping of Symantec product and accomplice integrations, gratify hunt recommendation from: https://www.symantec.com/integration.
Symantec company (NASDAQ: SYMC), the realm's main cyber safety business, helps companies, governments and individuals comfortable their most valuable data anywhere it lives. organizations internationally appear to Symantec for strategic, built-in options to notice after towards refined attacks across endpoints, cloud and infrastructure. Likewise, a global group of more than 50 million americans and families matter on Symantec's Norton and LifeLock product suites to protect their digital lives at home and across their instruments. Symantec operates one of the most world's largest civilian cyber intelligence networks, permitting it to contemplate and present protection to towards probably the most advanced threats. For more information, gratify consult with www.symantec.com or join with us on facebook, Twitter, and LinkedIn.
observe TO U.S. EDITORS: if you would enjoy additional info on Symantec corporation and its products, gratify consult with the Symantec Newsroom at http://www.symantec.com/information.
Symantec and the Symantec logo are trademarks or registered trademarks of Symantec supplier or its associates within the U.S. and different nations. different names can live emblems of their respective house owners.
forward-looking STATEMENTS: Any forward-looking indication of plans for products is preliminary and totality future unlock dates are tentative and are discipline to exchange. Any future unlock of the product or deliberate adjustments to product skill, performance, or characteristic are domain to ongoing comparison by means of Symantec, and might or may likewise now not live applied and may now not live regarded company commitments with the aid of Symantec and should now not live relied upon in making purchasing decisions.
1 supply: ESG research, hazard Detection and Response Survey, December 2018.
2 source: ESG analysis document, 2019 technology Spending Intentions Survey, February 2019.
three supply: ESG master Survey results, Cybersecurity panorama: The Evolution of business-classification companies and systems, October 2018.
MOUNTAIN VIEW, Calif.--(business WIRE)--
greater than 120 companions, together with AWS, field, IBM safety, Microsoft, Oracle, ServiceNow and Splunk, commit to Symantec’s built-in Cyber protection Platform
Symantec Corp. (SYMC), the world’s main cyber security enterprise, nowadays announced that more than a hundred and twenty corporations occupy joined forces with Symantec to drive down the imbue and complexity of cyber protection, while improving response instances to protect organisations in opposition t refined threats. This comprises principal players enjoy AWS, container, IBM safety, Microsoft, Oracle, ServiceNow and Splunk, as well as dozens of alternative know-how innovators, who are now constructing or supplying more than 250 items and services that combine with Symantec’s built-in Cyber defense (ICD) Platform.
This remarkable business collaboration displays a “platform shift” within the cyber protection industry, as unusual research from enterprise strategy group (ESG) suggests business customers want to consolidate providers and adopt greater integrated structures backed via an open ecosystem.
integrated protection improves safety through expanding the speed and effectiveness, whereas enormously cutting back the supplies required. To execute that shift even easier, Symantec likewise nowadays announced essential innovations – including a brand unusual ordinary data change, shared management capabilities, and upgraded information loss prevention utility that palliate customers cease untrusted apps before they compromise exclusive information. totality are developed on Symantec’s ICD Platform, which provides a unified framework for counsel insurance policy, danger coverage, id management and compliance across endpoints, networks, purposes, and clouds.
“There’s a seismic shift occurring in cyber safety,” mentioned knack Gilliland, EVP and GM enterprise products, Symantec. “The historical routine of fighting cyber-assaults the exhaust of fragmented materiel has become too tangled and costly to control. integrated platforms are the longer term. We’re disdainful to live main this platform shift with a transparent vision and successful portfolio – together with a whole lot of companions and thousands of specialists working daily on the front lines to present protection to their customers. we're fully convinced that their top-quality protection going ahead is an built-in defense.”
New analysis Demonstrates the want for built-in structures
ESG currently posted unusual consumer research showcasing how the inability of a cohesive safety technology strategy creates actual problems for agencies, main valued clientele to are looking for greater built-in platforms and fewer, more strategic providers. Key findings in line with the analysis include:
“well-nigh two-thirds of tremendous firms surveyed exhaust at the least 25 distinctive cyber protection items. For security operations centers, managing disparate materiel can live ineffective, expensive, and time drinking, certainly because the scarcity of cyber protection competencies,” pointed out Jon Oltsik, senior valuable analyst and fellow, ESG. “This explains why CISOs wish to consolidate and combine their protection infrastructure with systems and open architectures that give advanced developer support and convey a associate ecosystem with potent third-celebration integrations.”
Symantec Integrates items, functions and companions
Symantec begun constructing ICD two and a half years in the past with its acquisition of Blue Coat methods, which delivered choicest-of-breed net and cloud safety technologies to Symantec’s market-main endpoint, e-mail and facts loss prevention (DLP) technologies. on the time, Symantec saw and heard that valued clientele had been spending big time and substances to combine point technologies in an pains to derive upright cost from their cyber safety investments. So, the business invested in a methodology and roadmap to deliver an built-in platform that enormously reduces can imbue of operations whereas enhancing the speed and accuracy of prevention, detection and response in an pains to reduce risk.
when you account that then, Symantec has:
ICD Platform Earns broad Ecosystem aid
Symantec now has more than a hundred and twenty partners in TIPP, who are pile or providing greater than 250 unusual purposes and capabilities that combine with Symantec’s ICD Platform, so business customers can reduce back the can imbue and complexity of their protection operations. in addition, Symantec is now launching a brand unusual “Innovation Playground” software inside TIPP to simplify integration with startups. the brand unusual program will allow startup teams to leverage Symantec APIs and capitalize entry to products, engineering materials, and customer innovation days.
“in an pains to reduce protection operations complexity and fight these days’s more and more sophisticated adversary, companies requisite products that work as a platform as a substitute of an army of point items working in silos,” talked about Oliver Friedrichs, VP of security automation and orchestration at Splunk. “Splunk’s aid for the ICD Platform gives their joint shoppers with consolidated views across their safety infrastructure, including incidents flowing from endpoint, internet, network and e mail protection options.”
“At container, safety is a usurp priority and we're dedicated to presenting their clients with effective controls to offer protection to their sensitive content,” spoke of Niall Wall, senior vice president of companions at field. “Symantec is a founding member of the container believe Ecosystem. we're enthusiastic about Symantec’s integrated Cyber defense and how it will assist our mutual shoppers reduce risk of facts loss, observe advanced threats, and seamlessly compile their security capabilities.”
“protection analysts these days cope with more and more complicated threats, fragmented safety tools, and siloed organizations,” observed rich Telljohann, director of business pile at IBM safety. “To fight this we're considering that the cyber protection landscape is annoying a shift to built-in systems in an pains to reduce complexity and price. we occupy developed an integration using Symantec ICD change, so the IBM Resilient Incident Response Platform can provide ingenious orchestration, automation, and enrichment of incidents caused with the aid of Symantec ICD, allowing analysts to reply intelligently to threats.”
ICD Platform Drives consumer Adoption and value
As evidenced by Symantec’s recent quarterly profits, more and more shoppers are lamentable beyond particular person products to undertake the ICD platform and portfolio. for example:
“The casual panorama they totality face isn't static and is normally on the flow, as are their purchasers and personnel, so techniques to deal with that configuration of environment are very complicated,” observed Emily Heath, vice president and chief suggestions safety officer, United airways. “Visibility of your environment and integration of solutions are a key a portion of that method. for example, if one protection handle catches whatever, it's a lot extra efficient for us if these controls are integrated and may discourse seamlessly with each different to assist with precise time detection. moreover, if protection providers execute the pains to combine across the stack so they don’t must, that effects in a honest improved result.”
Symantec Extends ICD Platform with unusual facets & services
Symantec is introducing three unusual know-how innovations these days that prolong ICD for shared intelligence and shared administration throughout discrete expertise components, as well as unusual “hazard aware” information protection capabilities:
For extra guidance on ICD, gratify hunt recommendation from: www.symantec.com/icd.
For greater particulars about TIPP, gratify hunt recommendation from: https://www.symantec.com/expertise-companions.
For extra particulars on how Symantec and companions are leading the shift to integrated Cyber protection, gratify hunt recommendation from: https://www.symantec.com/blogs/feature-experiences/united-we-stand
For greater details on the cyber protection platform shift, gratify hunt recommendation from: https://www.symantec.com/blogs/characteristic-studies/cyber-safety-platform-shift-extra-relaxed-less-complicated
to contemplate an in depth mapping of Symantec product and partner integrations, gratify visit: https://www.symantec.com/integration.
Symantec organisation (SYMC), the realm's main cyber protection company, helps agencies, governments and americans comfortable their most valuable information anyplace it lives. companies across the world appear to Symantec for strategic, integrated options to safeguard in opposition t refined attacks across endpoints, cloud and infrastructure. Likewise, a global group of greater than 50 million people and households matter on Symantec's Norton and LifeLock product suites to protect their digital lives at domestic and across their contraptions. Symantec operates one of the world's greatest civilian cyber intelligence networks, enabling it to notice and give protection to against essentially the most superior threats. For more information, gratify talk over with www.symantec.com or connect with us on facebook, Twitter, and LinkedIn.
be cognizant TO U.S. EDITORS: if you'd enjoy additional info on Symantec organisation and its products, gratify hunt recommendation from the Symantec Newsroom at http://www.symantec.com/news.
Symantec and the Symantec brand are emblems or registered logos of Symantec corporation or its associates within the U.S. and other international locations. different names could live trademarks of their respective owners.
ahead-searching STATEMENTS: Any ahead-looking indication of plans for items is preliminary and totality future unencumber dates are tentative and are discipline to exchange. Any future release of the product or planned changes to product capacity, functionality, or characteristic are subject to ongoing evaluation with the aid of Symantec, and may or can likewise not live carried out and may not live regarded enterprise commitments by means of Symantec and may no longer live relied upon in making paying for selections.
1 source: ESG analysis, casual Detection and Response Survey, December 2018.
2 supply: ESG research record, 2019 technology Spending Intentions Survey, February 2019.
three supply: ESG master Survey outcomes, Cybersecurity panorama: The Evolution of business-type vendors and structures, October 2018.
View source edition on businesswire.com: https://www.businesswire.com/information/domestic/20190227005565/en/
While it is very difficult job to select dependable certification questions / answers resources with respect to review, reputation and validity because people accumulate ripoff due to choosing wrong service. Killexams.com execute it positive to serve its clients best to its resources with respect to exam dumps update and validity. Most of other's ripoff report complaint clients arrive to us for the brain dumps and pass their exams happily and easily. They never compromise on their review, reputation and property because killexams review, killexams reputation and killexams client self-confidence is valuable to us. Specially they recall supervision of killexams.com review, killexams.com reputation, killexams.com ripoff report complaint, killexams.com trust, killexams.com validity, killexams.com report and killexams.com scam. If you contemplate any False report posted by their competitors with the denomination killexams ripoff report complaint internet, killexams.com ripoff report, killexams.com scam, killexams.com complaint or something enjoy this, just preserve in intelligence that there are always unpleasant people damaging reputation of expedient services due to their benefits. There are thousands of satisfied customers that pass their exams using killexams.com brain dumps, killexams PDF questions, killexams exercise questions, killexams exam simulator. Visit Killexams.com, their sample questions and sample brain dumps, their exam simulator and you will definitely know that killexams.com is the best brain dumps site.
1Z0-206 test prep | C2010-593 study guide | 4A0-102 braindumps | 200-710 brain dumps | 000-288 test prep | 500-301 VCE | ST0-303 exam prep | 9A0-383 dumps questions | 000-875 questions and answers | 000-N07 brain dumps | 000-783 cheat sheets | 000-046 questions and answers | CNA exercise questions | VCI550 examcollection | 000-001 exercise test | 250-251 questions answers | 000-M227 actual questions | 101-400 exercise test | UM0-100 test prep | 117-199 exercise test |
Kill your 250-323 exam at first attempt!
We are notified that an imperative issue in the IT business is that there is unavailability of significant worth prep materials. Their exam preparation material gives totality of you that you should recall an certification exam. Their Symantec 250-323 Exam will give you exam question with confirmed answers that reflect the genuine exam. They at killexams.com are made plans to empower you to pass your 250-323 exam with towering scores.
If you are inquisitive about passing the Symantec 250-323 exam to start earning? killexams.com has forefront developed Data Protection Administration for(R) Windows using NBU 5.0 test questions that will execute positive you pass this 250-323 exam! killexams.com delivers you the foremost correct, current and latest updated 250-323 exam questions and out there with a 100 percent refund guarantee. There are several firms that present 250-323 brain dumps however those are not amend and latest ones. Preparation with killexams.com 250-323 unusual questions will live a best thing to pass 250-323 exam in straight forward means. We are totality cognizant that a significant drawback within the IT business is there's an absence of property study dumps. Their test preparation dumps provides you everything you will occupy to live compelled to recall a certification test. Their Symantec 250-323 exam offers you with test questions with verified answers that replicate the actual test. These Questions and Answers present you with the expertise of taking the particular exam. prime property and worth for the 250-323 exam. 100% guarantee to pass your Symantec 250-323 exam and acquire your Symantec certification. They occupy a current at killexams.com are committed to assist you pass your 250-323 exam with towering scores. The probabilities of you failing your 250-323 exam, once memorizing their comprehensive brain dumps are little. Symantec 250-323 is rare totality round the globe, and likewise the business and programming arrangements gave by them are being grasped by each one of the organizations. They requisite palliate in driving an outsized compass of organizations on the far side any doubt. So much reaching learning of 250-323 eam are viewed as a vital capability, and likewise the specialists certified by them are exceptionally prestigious altogether associations.
Great 250-323 items: they occupy their specialists Team to guarantee their Symantec 250-323 exam questions are dependably the latest. They are for the most portion exceptionally comfortable with the exams and testing focus.
How they preserve Symantec 250-323 exams updated?: they occupy their uncommon approaches to know the latest exams data on Symantec 250-323. Once in a while they contact their accomplices exceptionally acquainted with the testing focus or now and again their clients will email us the latest criticism, or they got the latest input from their dumps advertise. When they discover the Symantec 250-323 exams changed then they update them ASAP.
Unconditional promise?: on the off casual that you really arrive up short this 250-323 Data Protection Administration for(R) Windows using NBU 5.0 and don't requisite to sit tight for the update then they can give you complete refund. Yet, you ought to dispatch your score acknowledge to us with the goal that they can occupy a check. They will give you complete refund quickly amid their working time after they accumulate the Symantec 250-323 score report from you.
Symantec 250-323 Data Protection Administration for(R) Windows using NBU 5.0 Product Demo?: they occupy both PDF adaptation and Software variant. You can check their product page to perceive what it like.
killexams.com Huge Discount Coupons and Promo Codes are as under;
WC2017: 60% Discount Coupon for totality exams on website
PROF17: 10% Discount Coupon for Orders greater than $69
DEAL17: 15% Discount Coupon for Orders greater than $99
DECSPECIAL: 10% Special Discount Coupon for totality Orders
At the point when will I accumulate my 250-323 material after I pay?: Generally, After successful payment your username/password are sent at your email address inside 5 min. live that as it may, if any deferral in bank side for installment approval, at that point it takes minimal longer.
250-323 Practice Test | 250-323 examcollection | 250-323 VCE | 250-323 study guide | 250-323 practice exam | 250-323 cram
Killexams C9560-507 examcollection | Killexams P2090-045 pdf download | Killexams 000-646 free pdf | Killexams 000-939 exam questions | Killexams 1Z0-041 braindumps | Killexams 000-399 test questions | Killexams HP0-A01 braindumps | Killexams QIA questions and answers | Killexams GB0-363 actual questions | Killexams CCN test prep | Killexams 250-428 cheat sheets | Killexams 650-575 mock exam | Killexams HP0-A24 free pdf download | Killexams HP2-Z32 cram | Killexams 6102 actual questions | Killexams HP2-E32 exam prep | Killexams C9530-410 VCE | Killexams HP3-R95 study guide | Killexams S10-210 test prep | Killexams P2140-020 dumps |
Exam Simulator : Pass4sure 250-323 VCE Exam Simulator
Killexams 1Z0-936 dumps questions | Killexams 000-630 test prep | Killexams 000-853 braindumps | Killexams HP2-Z21 exam questions | Killexams 00M-656 exercise test | Killexams CAT-220 actual questions | Killexams MD0-205 exercise Test | Killexams 312-50v7 study guide | Killexams 000-638 exam prep | Killexams 190-711 actual questions | Killexams P2090-054 questions and answers | Killexams CGRN examcollection | Killexams H12-211 mock exam | Killexams 117-202 test prep | Killexams MOS-W2E actual questions | Killexams 9A0-182 free pdf | Killexams M2035-725 free pdf | Killexams 000-612 questions and answers | Killexams COG-180 braindumps | Killexams 350-023 brain dumps |
Toigo Partners International
In the late 1990s, Gal Naor started a company, StorWiz (he later changed the denomination to StorWize), to further a technology he developed for delivering data compression at wire speed. Not only was this a detached view and one that struck me as much more efficient than most algorithmic data deduplication approaches in vogue at the time, it had the nifty edge of being software-based. You could apply the technology to just about any type of storage to squeeze out the bandwidth required for data transfers and space for storing bits when they came to rest. IBM bought StorWize in 2010, making Naor and his investors rather well to do.
That was the eventual I had heard of Naor for years. I thought he'd had his fill of storage technology and gotten out of the business just in time to miss the industry consolidation that dramatically reduced the number of vendors in recent years. As it turned out, Naor had "gone quiet" for the past seven years and not just to bask in the afterglow of his success. He was engaged in sedate R&D for his next stout adventure. Now, with unusual technology based on more than 50 patents, Naor has re-entered the fray at the helm of software-defined storage startup StorOne.
His unusual tech, called TRU Storage, is closer to what they totality thought software-defined storage would live when the SDS concept was first floated a few years back. The acronym TRU stands for Total Resource Utilization. In this case, it's a designation that's more than aspirational.
I've been acquainting myself with TRU Storage over the eventual few months. With it, StorOne storage might just set the bar for SDS going forward. (I occupy no stake in the company or condense to promote their wares.)Total Resource Utilization
Gartner reported eventual summer that SDS and hyper-convergence had reduced the cost per terabyte by increasing the amount of storage a single administrator could manage. However, they had likewise caused a 10% diminish in the utilization efficiency of storage capacity across the enterprise. The understanding for the utilization fail: Storage was being siloed behind different hypervisors in a artery that prohibited shared exhaust by different workloads operating under different hypervisor brands.
With S1, the StorOne TRU Storage product name, neither the workload, nor the hypervisor, nor the hardware used to build the storage infrastructure matters. StorOne storage technology creates universal storage pools that can comprise any storage gear connected via any protocol and enables any workload to exhaust that resource. Block, file and protest storage can participate the same resource, volume and drive. Remarkably, S1 optimizes the overall infrastructure's performance and capacity to more than 90% of advertised peaks. That means you sacrifice fewer IOPS and terabytes in an S1 environment compared with other current approaches, live it converged or hyper-converged infrastructure.
StorOne's results occupy yet to live evaluated by the Storage Performance Council (SPC) or other benchmarking outfits. Publishing results would likely prove problematic anyway, given the pushback the SPC received when it published the results of DataCore Software testing a pair years ago. enjoy StorOne, software-defined storage vendor DataCore took an unconventional path to accelerating I/O -- a software shim that created a parallel I/O processing engine out of unused ratiocinative CPU cores, thereby accelerating I/O processing and reducing latency by extraordinary levels.
Big box vendors enjoy Hewlett Packard Enterprise and IBM thought the resulting comparison unfair, since it demonstrated the same IOPS and latencies could live obtained from commodity servers and white box arrays as from highly configured stout iron arrays. Smoke still billows from vendor ears, and a few even present off-the-record disparagement of SPC methodology to this day.A potential disrupter
StorOne storage is similar to DataCore in terms of its disruptive potential, but it is likewise different. TRU Storage does not exhaust DRAM caching as DataCore does. It hardly uses caches at all. S1 software runs as a virtual machine under ESXi. It uses a surprisingly low amount of resources in an all-virtual environment to immediately deliver IOPS that exceed the performance-leading all-flash arrays, according to StorOne lab tests.
TRU Storage is closer to what they totality thought software-defined storage would live when the concept was first floated a few years back.
Recently, StorOne released a test result document, demonstrating 1.7 million IOPS using 24 Western Digital glint drives (random reads), 15 gigabyte per second sequential reads, 7.5 GBps sequential writes and 10 GBps for mixed workloads of 80/20 reads/writes. By comparison, StoreOne noted, an all-flash array competitor in the market required four times the hardware and expense to deliver only 1.5 million IOPS. For the record, these are internal tests performed by StorOne and not by gauge benchmark testing outfits.
A persistent integrity guarantee promises complete recovery from any hardware or environment failure without data loss. This is enabled by an integrated enterprise data protection and data retention feature that permits zero-time backup and restore and unlimited snapshots with no performance degradation. StorOne storage delivers this functionality without requiring rejiggering RAID levels on connected equipment, adding memory or processor or changing configurations.
S1 is quite literally plug-and-play.
Perhaps the most disruptive feature of StorOne storage is its cost tag. Naor says S1 will live offered as software, as a service or bundled with white box arrays for the cost of a penny per gigabyte from the software-defined storage vendor. That is lower than most cloud storage offerings, totality of which don't present the performance characteristics or integrity guarantee of S1.
I'll live watching to contemplate how the tech plays out at scale and in geographically distributed installations, including hybrid cloud on-premises infrastructure. When I bring this up, Naor simply smiles his "just stand by and live patient" smile, as he insists TRU Storage technology will scale without problems. Given his record of technological success, I'm willing to give him the capitalize of the doubt.
Coitally delivered microbicide gels containing antiretroviral drugs are valuable for HIV prevention. However, to date, microbicides occupy contained entry or transpose transcriptase inhibitors that obstruct early steps in virus infection and thus requisite to live given as a preexposure dose that interferes with sexual practices and may confine compliance. Integrase inhibitors obstruct late steps after virus infection and therefore are more suitable for post-coital dosing. They first determined the kinetics of strand transfer in vitro and confirmed that integration begins about 6 hours after infection. They then used a repeat-challenge macaque model to assess efficacy of vaginal gels containing integrase strand transfer inhibitors when applied before or after simian/human immunodeficiency virus (SHIV) challenge. They showed that gel containing the strand transfer inhibitor L-870812 protected two of three macaques when applied 30 min before SHIV challenge. They next evaluated the efficacy of 1% raltegravir gel and demonstrated its ability to protect macaques when applied 3 hours after SHIV exposure (five of six protected; P < 0.05, Fisher’s exact test). Breakthrough infections showed no evidence of drug resistance in plasma or vaginal secretions despite continued gel dosing after infection. They documented rapid vaginal absorption reflecting a short pharmacological lag time and noted that vaginal, but not plasma, virus load was substantially reduced in the breakthrough infection after raltegravir gel treatment. They provide a proof of concept that topically applied integrase inhibitors protect against vaginal SHIV infection when administered shortly before or 3 hours after virus exposure.INTRODUCTION
HIV-1 continues to spread globally, highlighting the requisite to develop efficacious biomedical interventions to confine its transmission. In addition to vaccine development, there are several antiretroviral (ARV) drug–based intervention strategies currently being advanced, including oral preexposure prophylaxis (PrEP) treatment as prevention as well as topical PrEP with gels or other ARV delivery methods such as intravaginal rings and tablets (1–3). ARV gels occupy several advantages for HIV prevention. When applied to the mucosal site of virus exposure, gels can rapidly dose tissues with drug concentrations that are much higher than those achieved by oral dosing and with minimal systemic drug exposures and drug toxicities (3–9). Topical gels are user-controlled and can live optimally formulated with a single drug or in combination for both vaginal and rectal application (4–6, 10).
The CAPRISA 004 trial evaluated the safety and effectiveness of a vaginal gel containing 1% tenofovir (TFV) and provided the first evidence of efficacy by this intervention strategy. The study demonstrated a 39% reduction of HIV acquisition in women who applied the gel pericoitally (1). Effectiveness was relative on adherence and was organize to enlarge to 54% in women who reported frequent gel exhaust (>80% adherence) compared to only 28% in women who were <50% adherent. A subsequent study (VOICE) evaluating the same gel formulation in a noncoital daily dosing modality was stopped because of the absence of protection (2). TFV testing in plasma revealed penniless adherence among participants, likely explaining the lack of efficacy (3). These data and similar findings from oral PrEP studies highlight the challenges of identifying intervention strategies that occupy both towering biological efficacy and enhanced user compliance (4).
Coitally used topical gels are valuable HIV prevention methods. However, to date, totality such products reckon on a preexposure dose that can tamper with sexual practices, and may live limited by partner’s acceptance and the requisite to anticipate sex. They reasoned that a topical product that can live applied by women after sex will occupy less repercussion on sexual practices, occupy better user control, and circumvent the requisite for sex anticipation and partner acceptance. These advantages can totality potentially enhance compliance and effectiveness. However, totality topical ARV-based gels in progress exhaust entry or transpose transcriptase (RT) inhibitors that obstruct early steps in the virus infection cycle, which raises questions about their suitability for postexposure prophylaxis (PEP) (1, 5–7). Macaque models of rectal or vaginal transmission of the simian immunodeficiency virus (SIV) or the chimeric simian/human immunodeficiency virus (SHIV) occupy provided valuable data confirming the efficacy of topical gels with RT inhibitors such as TFV and MIV150 when applied before virus challenge, but demonstrated loss or substantial reduction in efficacy when applied 1 to 2 hours after virus challenge (8–10). These data likely reflect the requisite to adequately dose mucosal tissues with RT inhibitors before virus exposure and insinuate that drugs from different classes that target later steps in virus infection may live more efficacious for PEP.
HIV or SIV integration into the host DNA is the eventual step before an irreversible infection of a cell takes place. Integration is a multistep process catalyzed by the viral integrase that follows transpose transcription and starts in the cytoplasm with 3′-end processing of viral DNA, continues with translocation of the processed DNA to the nucleus, and is completed by integrating the viral DNA into the host chromosome by a strand transfer mechanism (11, 12). The integration process can live inhibited at various stages by three main classes of integrase inhibitors: 3′-processing inhibitors (13), strand transfer inhibitors (14), and macromolecular tangled LEDGF/p75-IN inhibitors (15). Strand transfer inhibitors are the most developed and occupy been validated as potent inhibitors of HIV replication in vitro, ex vivo, in animal studies, and in clinical trials (16, 17). The mechanism of action of strand transfer inhibitors is characterized by their ability to chelate the Mg2+ ions in the catalytic core domain of integrase, thereby disrupting the interaction between the integrase/viral complementary DNA preintegration tangled and the target DNA (18). The only clinically approved integrase inhibitors licensed for the treatment of HIV-infected persons are raltegravir (RAL), elvitegravir, and dolutegravir, totality of which are strand transfer inhibitors (14, 19). The compound L-870812 (L-812) is a potent investigational strand transfer inhibitor and has been shown to live efficacious in reducing SIV replication in macaques (16). For PEP, blocking the eventual step in virus integration by strand transfer inhibitors can live advantageous because it can extend the post-coital dosing window (14, 20). RAL and L-812 are equally potent on both HIV and SIV integrase, with IC50 (50% inhibitory concentration) in the nanomolar compass (1 to 4 nM), which provides an chance to test in macaque models the concept of topical prophylaxis by this class of drugs for both pre- and postexposure protection (16, 17).
Here, they used a repeat low-dose vaginal challenge macaque model to evaluate the efficacy of gels containing L-812 or RAL administered before or after virus challenge, respectively. This well-established macaque model has several advantages, including the exhaust of pigtailed macaques, which occupy a menstrual cycle and vaginal anatomy similar to women, an inoculum dose with viral RNA levels in the compass similar to those detected in seminal fluid, twice-weekly virus challenges to mimic high-risk human exposure, and an SHIVSF162p3 inoculum that uses an R5-tropic envelope similar to that of most transmitted HIV (10, 21, 22). The repeated challenges in this model occupy the added edge of increasing statistical power without requiring big groups of animals because they allow measurement of protection over more than one transmission event per animal. They likewise performed time-of-drug addition studies in vitro to define the window for strand transfer inhibition and to better inform in vivo dosing.RESULTS Gel formulation and repercussion of vaginal fluids on antiviral activity
L-812 was successfully formulated in a hydroxyethyl cellulose (HEC) gel at a maximum solubility of 2.3 mg/ml (0.23%). Because of higher water solubility, RAL was formulated in a HEC gel at a concentration of 10 mg/ml (1%). Both gels were clear, viscous, and free of particulates and remained highly dynamic for up to 1 year at play temperature. To investigate whether biological factors present in the vagina, including mucus, enzymes, and microflora, may compromise the stability and potency of RAL gel, they assessed the antiviral activity of RAL gel incubated in cervicovaginal fluids (CVFs). motif 1 shows that CVF had no repercussion on RAL activity because no disagreement in IC50 was observed between RAL incubated in CVF (IC50 = 2.6 ± 1.1 nM) or saline (1.7 ± 1.2 nM).Fig. 1. Antiviral activity of RAL gel is maintained in the presence of vaginal fluids.
A TZM-bl reporter cell line was used to evaluate antiviral activity (IC50) of RAL gel preincubated (24 hours) in saline buffer or CVF. Data are means ± SE of three independent experiments.Time-of-drug addition reveals a wide window for inhibition by integrase inhibitors
To better define the timing of transpose transcription and integration and to inform the dosing modality in vivo, they performed time-of-drug addition experiments using single-cycle infections of TZM-bl cells with vesicular stomatitis virus (VSV)–pseudotyped HIV-1. The kinetics of postexposure inhibition by the RT inhibitor TFV was compared with that of RAL. motif 2 shows that TFV maintained towering (>95%) protection up to 2 hours after infection, but was only ~50% protective when added at 5 hours after infection. In contrast, RAL provided towering protection (>90%) at 6 hours and remained above 50% protection for up to 10 hours after infection. These data insinuate that strand transfer is delayed by at least 4 hours after transpose transcription, providing a longer window to obstruct infection with integrase inhibitors than inhibitors of transpose transcription.Fig. 2. Kinetics of the window of inhibition by RT and integrase inhibitors.
Protection of TZM-bl cells from infection with VSV-HIV was evaluated after addition of the RT inhibitor TFV or the integrase inhibitor RAL at the indicated times after infection. Data are means ± SE of three independent experiments.Preexposure protection by a vaginal integrase inhibitor gel
We first evaluated whether topically applied integrase inhibitors administered before virus challenge protected macaques from SHIV infection. Three pigtailed macaques received vaginal gel containing 0.23% L-812 30 min before vaginal SHIVSF162p3 exposure. Infection outcome after 14 twice-weekly vaginal challenges was evaluated against 10 untreated controls receiving placebo gel (1 real-time and 9 historic controls). totality controls received the same placebo gel and were challenged with the same virus stock under identical experimental conditions. In this model, pigtailed macaques are more susceptible to infection during the late luteal aspect of the menstrual cycle (10, 23). As previously described, the risk for infection was calculated per month or menstrual cycle (10). motif 3A shows the infection rates in animals treated with L-812 and placebo gel. Nine of 10 controls (90%) became infected after 14 challenges over a 2-month period; seven, including the real-time control, were infected after eight challenges (1 month), and two were infected during the second month. In contrast, two of the three macaques treated with L-812 gel remained uninfected after 14 challenges (estimated efficacy = 76%; P = 0.057, Fisher’s exact test); the breakthrough infection occurred after nine challenges (week 5), whereas both protected animals remained seronegative and had undetectable SHIV sequences in plasma or PBMCs throughout the 10-week follow-up period. L-812 gel efficacy was estimated at 76% on the basis of 9 of 13 infections per months (or cycles) at risk among controls and 1 of 6 for treated animals.Fig. 3. Protection by PrEP and PEP with vaginal gels containing integrase inhibitors.
Survival curves portray the cumulative percentage of uninfected macaques as a duty of the number of months at risk for infection during the study period (eight challenges per month). (A) Gel containing L-812 (solid line) or placebo (dotted line) was applied vaginally 30 min before each SHIV exposure (up to 14 SHIV exposures). Controls comprise one real-time (solid circle) and nine historic controls. (B) Gel containing RAL (solid line) or placebo (dotted line) was applied vaginally 3 hours after SHIV exposure (up to 20 SHIV exposures).Postexposure protection by RAL gel
We next explored the efficacy of 1% RAL gel applied 3 hours after vaginal SHIV exposure. The 3-hour dosing interval falls within the dosing window for maximal in vitro inhibition of strand transfer and is behaviorally feasible for post-coital application. motif 3B shows infection outcomes in macaques that were challenged twice weekly for 2.5 months (about two menstrual cycles) with SHIVSF162p3 and administered placebo (n = 4) or 1% RAL (n = 6) gel 3 hours after each virus challenge. totality four macaques that received placebo gel became infected by 10 weeks (20 challenges). In contrast, five of six macaques treated with RAL gel 3 hours after SHIV exposure remained uninfected after 20 SHIV exposures and the 10-week follow-up period. totality infected macaques, including the breakthrough infection, exhibited typical SHIV RNA viremia and detectable proviral DNA in PBMCs and seroconverted 1 to 3 weeks after first detectable plasma SHIV RNA was observed. Risk for infection differed by study group (P < 0.05, Fisher’s exact test), with RAL gel efficacy estimated at 84% on the basis of 4 of 7 infections per months (or cycles) at risk among controls and 1 of 11 for treated animals. Together, these data insinuate that topically applied integrase inhibitors can forestall vaginal infection when administered shortly before or up to 3 hours after SHIV exposure.Systemic drug concentrations after vaginal gel dosing
Measuring drug exposure in blood is faultfinding to understanding kinetics of drug release and systemic absorption after vaginal gel dosing. Systemic drug exposures are likewise valuable for determining repercussion on acute viremia and emergence of drug resistance in animals that fail gel prophylaxis and continue receiving gel treatment. They measured L-812 and RAL concentrations in plasma 30 min after each gel administration to determine systemic drug exposure at time of challenge and likewise assessed the repercussion of the menstrual cycle on vaginal drug absorption. They occupy previously noted with gels containing TFV or emtricitabine (FTC) that systemic drug exposure peaks within 1 hour after gel dosing and is highly influenced by the menstrual cycle with higher drug concentrations in plasma observed during the progesterone-dominated luteal aspect when the vaginal epithelium is thin (24, 25). They analyzed longitudinally both progesterone and drug concentrations in plasma in totality macaques that were treated with L-812 or RAL gel (Fig. 4, A and B). With the exception of one (PMl), totality macaques experienced at least two menstrual cycles during the study period. Plasma drug concentrations 30 min after vaginal dosing showed similar trends in totality animals with substantially higher concentrations consistently detected after peak progesterone. The addupto concentration of L-812 and RAL 1 week after peak progesterone (late luteal phase) was 115.3 ± 20.8 ng/ml (range, 74 to 140) and 111 ± 31.3 ng/ml (range, 0 to 260) compared to only 1.5 ± 0.5 ng/ml (range, 0 to 6) and 5.8 ± 4.9 ng/ml (range, 0 to 39.8) 1 week before peak progesterone (late follicular phase). The data confirm that both drugs were rapidly released from the HEC-based gel formulation. The longitudinal analysis of plasma drug concentrations in the two breakthrough infections (PBg-2 and PSz-1) revealed similar peak drug levels and absorption trends to animals that were protected. PSz-1 had detectable RAL in plasma at the estimated time of infection, 7 days (226 ng/ml) to 10 days (259 ng/ml) before the first detectable SHIV RNA. However, PBg-2 had undetectable L-812 at day 7 and 17 ng/ml at day 10. Although limited to only two animals, these results Do not demonstrate a transparent association between drug concentrations in plasma and protection.Fig. 4. Longitudinal analysis of plasma drug and progesterone concentrations in pigtailed macaques dosed with vaginal gels containing integrase inhibitors.
(A) Three macaques were dosed twice weekly with L-812 gel (dotted line); shaded areas demonstrate progesterone concentrations. (B) Six macaques dosed twice weekly with RAL gel (dotted line); shaded areas demonstrate progesterone concentrations. totality drug concentrations were analyzed from plasma collected 30 min after each vaginal gel application. SHIV+ denotes first detectable SHIV RNA in plasma.Virus replication in breakthrough infections
We next explored the repercussion of continued vaginal gel dosing on plasma and vaginal virus shedding in macaques PBg-2 and PSz-1, which became infected despite receiving L-812 or RAL gel, respectively. Infected macaques continued to receive twice-weekly placebo (n = 5), L-812 (n = 1), or RAL (n = 1) gel treatment for up to 8 weeks (16 gel applications) after the first SHIV RNA was detected in plasma. Plasma SHIV RNA detected in both breakthrough infections was evaluated against the five real-time controls. Virus shedding was assessed only in the RAL failure and controls receiving placebo gel. motif 5A shows the virus load kinetics in both breakthrough infections compared to controls. The peak viremia in PBg-2 (6.08 log10 RNA copies/ml) and PSz-1 (6.7 log10 RNA copies/ml) was similar to the median peak viremia of the five untreated controls (7.01 ± 0.98 log10 RNA copies/ml), showing no disagreement in acute viremia (P = 0.29, Wilcoxon rank sum test). In contrast, Fig. 5B reveals that the peak vaginal SHIV RNA (3.5 log10 copies/ml) and the frequency (4 of 15) of SHIV RNA detected in vaginal fluids were both significantly lower in PSz-1 than in placebo-treated animals that had a median SHIV RNA peak of 5.2 log10 ± 0.42 copies/ml (P = 0.007) and frequency of 36 of 60 (P < 0.0001), respectively. The reduction in vaginal SHIV shedding could reflect the antiviral activity by RAL gel.Fig. 5. Plasma and vaginal virus loads in macaques with breakthrough infection and controls.
(A) Individual virus load kinetics in breakthrough infections under continued twice-weekly dosing with gel containing L-812 (diamonds) or RAL (circles) compared to median virus loads of controls (n = 5, dotted black line). Time 0 indicates first detection of SHIV in plasma. (B) Individual virus load kinetics in vaginal secretions collected twice weekly before dosing with gel containing RAL (solid line; big circles) or placebo (n = 4, black dotted lines). Filled symbols indicate samples sequenced for drug resistance in plasma and vaginal fluids. The broken line denotes the confine of quantitation of the virus load assay (50 copies/ml).No evidence of emerging drug resistance after continued gel dosing in breakthrough infections
Because L-812 and RAL were detected in plasma in the breakthrough infections, it was valuable to determine whether these systemic drug exposures led to drug resistance. Sequence analysis of the integrase region spanning the N-terminal and core domain (amino acids 1 to 234) in virus first detected in plasma showed that both breakthrough infections were initiated with wild-type virus (fig. S1). Plasma specimens collected at peak viremia and up to 8 weeks after infection totality revealed wild-type genotypes (Fig. 5A). To examine drug resistance emergence at the site of gel application, they likewise genotyped SHIV RNA isolated from vaginal secretions in the RAL breakthrough infection (fig. S1). Vaginal fluids with detectable SHIV (n = 4) were genotyped, and totality organize to live wild type (Fig. 5B). Thus, despite twice-weekly vaginal dosing for 8 weeks after infection, no evidence of drug resistance in plasma or genital secretions was observed (fig. S1).DISCUSSION
This study provides a proof of concept that topically applied strand transfer integrase inhibitors protect macaques against repeated vaginal SHIV challenges. Protection was observed when the vaginal gel was applied shortly before and, more importantly, 3 hours after virus challenge. The protection by postexposure dosing reflects the advantages of the late-acting strand transfer inhibitors that are needed several hours after virus entry, thus providing an optimal window for post-coital dosing that was previously not feasible with entry or RT inhibitors (8, 9). Because applying gel after sex may tamper less with sexual practices, their data support exploring unusual post-coital modalities with integrase inhibitors for enhanced acceptance and compliance in women.
We used single-round infections to determine the kinetics of transpose transcription and integration and demonstrate that in the HeLa-derived TZM-bl cells, strand transfer starts more than 6 hours after infection, consistent with previous findings in different cell infection systems (21, 22, 26, 27). The integration step may recall longer in less activated primary cells that are commonly present in vivo in which transpose transcription and integration proceed more slowly than in transformed cell lines (26, 28). Thus, it is likely that the dosing window in vivo may live longer than the 3 hours evaluated in this study. Integrase inhibitors, including RAL, are known to bind tightly to preintegration complexes with dissociation half-lives of >7 hours, which ensures longer antiviral activity in infected cells even if tissue drug concentrations subsequently spoil to suboptimal levels (19). They likewise note the detection of drug in plasma within 30 min of vaginal gel dosing, which reflects rapid absorption through vaginal tissues. The rapid absorption of RAL and the lack of intracellular activation insinuate that the pharmacological lag time for in vivo activity may live minimal. Additional macaque studies of longer postexposure gel applications are needed to further define the post-coital window of protection by strand transfer inhibitors.
We likewise document in pigtailed macaques changes in plasma drug levels during the menstrual cycle and solemnize higher concentrations during the progesterone-dominated luteal phase. These results reflect a higher vaginal permeability peaking during the luteal aspect likely due to thinner epithelium, increased porosity, changes in mucus composition, and other factors (23, 24, 29). The influence of the menstrual cycle on vaginal drug absorption likewise explains the cyclical changes in plasma concentrations of TFV and FTC they occupy previously observed in pigtailed macaques dosed with gels containing TFV and FTC (6). They likewise examined the relationship between plasma drug concentrations and vaginal efficacy because Cranage et al. previously organize a positive association between TFV concentration in plasma and the degree of rectal protection by rectal TFV gel (9). With only two breakthrough infections, they were unable to discern any trend because one animal had towering drug concentrations around the estimated time of infection and one did not. These results likely highlight the added complexity in identifying pharmacological markers of vaginal protection relative to rectal protection and the confounding role of the menstrual cycle modulating both susceptibility to infection and drug permeability (23). Nevertheless, the data demonstrate the usefulness of the pigtailed macaque model that has a menstrual cycle similar to that of women, and support similar evaluations in women to better define the repercussion of menstrual cycle and hormonal contraceptives on vaginal pharmacokinetic parameters and efficacy.
Both L-812 and RAL are potent drugs with IC50 in nanomoles; however, they organize that the concentrations in gels that conferred high, yet incomplete, in vivo protection were in the micromolar range, or about 1 million–fold higher than those concentrations needed for in vitro inhibition. The higher drug concentrations required for in vivo efficacy occupy been consistently observed with other gels containing entry or RT inhibitors and likely reflect the distribution kinetics of the drug through the mucosa to achieve concentrations needed to protect the big surface belt of the vagina for a significant period of time (6, 7, 10). Previous work with TFV gels in macaques has shown that the pharmacologically dynamic TFV-diphosphate (TFV-DP) concentrations in vaginal lymphocytes predict in vivo efficacy, and topical dosing by gel or intravaginal ring that achieved TFV-DP concentrations exceeding the in vitro IC95 values in these lymphocytes was associated with complete protection (10, 30). Thus, it is tempting to surmise that a similar pharmacological correlate will likewise apply to RAL. However, confirming this correlate will require measuring intracellular RAL concentrations in vaginal lymphocytes, which could live challenging because unlike intracellularly bound TFV-DP, RAL may diffuse out during the cell purification process as extracellular RAL concentrations decrease. Thus, alternative tissue testing methods are needed.
The potential for drug resistance to develop when prophylaxis fails raises concerns, especially with drugs that are likewise used for treatment. Prolonged systemic treatment of SHIV-infected macaques with L-812 has been organize to select drug-resistant variants with the integrase mutation (N155H) (20). They demonstrate no evidence of drug resistance emergence in plasma from either the L-812 or RAL breakthrough infection despite continued twice-weekly gel dosing for up to 8 weeks after infection. Although larger numbers of animals are needed to define incidence of resistance in animals failing prophylaxis, the finding of wild-type SHIV suggests that both gel failures are not due to a selection of a low-frequency drug-resistant variant in the challenge virus, and likely reflects insufficient selective pressure by the systemically absorbed drug from the twice-weekly gels. These systemic drug exposures are much lower than those observed from oral dosing and likely contribute to lower risks of drug resistance (20). Indeed, they organize no reduction in the acute viremia in both breakthrough infections compared to controls, further supporting the minimal systemic antiviral activity. These findings are similar to TFV gel breakthrough infections but disagree from those in macaques that fail oral PrEP in which reductions in virus loads and selection of drug-resistant variants occupy been observed (7, 9). Given that the antiviral activity from gels remains largely concentrated in the vaginal compartment, they likewise evaluated the viral population in the genital secretions from the RAL breakthrough infection. They detected only wild-type SHIV, but noted that, in contrast to plasma virus load, vaginal virus shedding was substantially reduced in this macaque. The suppression of virus shedding may reflect the antiviral activity from gel dosing, which may likewise occupy reduced drug resistance selection. These data are only from one animal and require confirmation, but they Do point to broader implications because reductions in vaginal virus shedding during acute infection may lower transmissibility.
Our study has several limitations. The virus challenges did not comprise cell-associated virus and were done in the absence of semen or semen-derived factors shown to enhance HIV infection in vitro (18). However, recent data insinuate runt repercussion of semen on vaginal SIV transmission in rhesus macaques (31). Also, SHIV exposures were made on intact vaginal mucosa without trauma associated with coitus, concurrent genital ulcers, or bacterial vaginosis, totality of which can enlarge the risk of HIV acquisition (26, 27). As previously noted, only two breakthrough infections were available to study vaginal SHIV shedding and drug resistance, and thus, these observations require confirmation in larger numbers of animals.
In conclusion, they demonstrate preclinical in vivo data that support the exhaust of topical integrase inhibitors for HIV prevention. They highlight the edge of using this class of drugs in unusual post-coital modalities that were previously not possible with entry or RT inhibitors. This study supports evaluation of this class of drug for HIV prevention, including minuscule molecules that Do not overlap with clinically approved integrase inhibitors in optimized gels or other dosage forms such as vaginal rings or tablets (28, 32, 33). The study likewise supports further evaluation of post-coital modalities in women for enhanced acceptability and compliance.MATERIALS AND METHODS Gel formulations
L-812 and RAL were provided by Merck and the National Institutes of Health (NIH) AIDS Research and Reference Reagent Program, respectively. L-812 was formulated at 0.23% (w/w) in a 2% HEC gel containing 20% propylene glycol, 0.02% propylparaben, 0.18% methylparaben, and 0.02% EDTA. RAL was formulated at 1% (w/w) in a 2% HEC gel containing 0.017 M phosphate-buffered saline (PBS) (pH 7.4), 0.02% propylparaben, 0.18% methylparaben, and 0.02% EDTA. A 2% HEC gel formulated without drug was used as a placebo control. Gels were stored at play temperature, and antiviral activity was confirmed throughout the course of the study with a TZM-bl reporter assay to measure drug susceptibility.Virus stock
SHIVSF162P3 (SIVmac239 backbone with an HIV-1 subtype B, CCR5-tropic envelope) was obtained from the NIH AIDS Research and Reference Reagent Program and was propagated in peripheral blood mononuclear cells (PBMCs) from pigtailed macaques as previously described (34, 35). The virus stock titer was calculated in pigtailed macaque PBMCs and diluted to the challenge dose of 10 TCID50 (median tissue culture infectious dose) (1.5 × 106 RNA copies per exposure).Antiviral activity and stability of RAL gel
TZM-bl cells (NIH AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH) were used to determine the IC50 of gels containing integrase inhibitors, and data were analyzed by GraphPad Prism (v5.02) software. For stability testing, 1% RAL gel (20 mM) was diluted 10-fold in PBS or macaque CVF and incubated overnight at 37°C. RAL-saline and RAL-CVF were then serially diluted (20-0 μM) in complete medium, and 100 μl was added to wells of a 96-well plate in triplicate. Complete medium (50 μl) containing TZM-bl cells (3 × 106/ml) was plated in each well. After 15 min of incubation, 50 μl of SHIVSF162p3 stock, diluted to a final concentration resulting in a signal of about 105 relative light units, was added to each well. After 48 hours of incubation at 37°C, 100 μl of medium was removed and replaced with 100 μl of Bright-Glo (Promega Corp.), and the luminescence was measured with PerkinElmer Victor X2 Multilabel Plate Reader. Inhibition was determined on the basis of reduction from the virus-only control and presented as the percentage of cells protected (mean ± SEM).Kinetics of postexposure inhibition
Time-of-drug addition experiments were carried out with single-cycle infections to determine the inhibition window for RT and integrase inhibitors. TFV or RAL was added to infected TZM-bl cells at concentrations exceeding IC99 (200 μM TFV or 20 μM RAL) at different times after infection (0 to 24 hours). Briefly, TZM-bl cells were preincubated with VSV-pseudotyped HIV-1 NL4-3-ΔE-EGFP (VSV-HIV) for 1 hour to establish infection. A VSV-pseudotyped virus was used to ensure that totality reported infectivity was derived from a single round of infection. Cells were washed twice with PBS and treated with 0.25% trypsin (Cellgro) to remove totality cell-bound and cell-free viruses. Infected cells were resuspended in complete medium and plated (3 × 104 per well) in triplicates in a 96-well plate. Drug was added at 1-hour time increments up to 24 hours. The percentage of cells protected at each time point was determined and plotted as % cells protected ± SEM relative to time when drug was added after infection.Efficacy studies
The efficacy of integrase inhibitors against vaginal transmission was evaluated in female pigtailed macaques under conditions similar to those described in other studies (6, 10). Macaques were administered gel (3 ml) vaginally and challenged with a low-dose SHIVSF162P3 inoculum (10 TCID50) twice weekly (every 3 to 4 days) for up to 10 weeks (about two menstrual cycles). totality animals were anesthetized and remained recumbent for 30 min after each gel application and 15 min after virus inoculation to minimize leakage. For preexposure efficacy measurements, macaques received placebo (n = 1) or 0.23% L-812 (n = 3) gel vaginally 30 min before each vaginal SHIV exposure (up to 14 challenges). For postexposure efficacy, anesthetized animals were challenged with SHIV (up to 20 challenges) and remained incumbent for 15 min after receiving the virus to minimize leakage and then returned to their cages. After 3 hours, macaques were anesthetized and administered 3 ml of placebo (n = 4) or 1% RAL (n = 6) gel. For each study, blood was collected 30 min after gel dosing to monitor for drug levels and SHIV infection. Virus challenges were stopped when a macaque became SHIV RNA-positive (SHIV+) in plasma. totality infected macaques continued to receive study gel (placebo, L-812, or RAL) twice weekly for up to 8 weeks after infection. totality experiments were done under highly controlled conditions by the same personnel with the same virus stock, inoculum dose, and procedures as described in previous studies (6). These studies adhered to the sheperd for the supervision and exhaust of Laboratory Animals (Institute for Laboratory Animal Research, 1996); totality procedures were approved by the Institutional Animal supervision and exhaust Committees of both the Centers for Disease Control and Prevention (CDC) and the Yerkes National Primate Research Center, Emory University.Monitoring systemic infection, virus shedding, and drug resistance
Systemic infection was monitored twice weekly by screening for SHIV RNA in plasma with a quantitative real-time transpose transcription polymerase chain reaction (PCR) assay with a sensitivity of 50 RNA copies/ml, as previously described (6, 34, 36). The estimated time of infection was defined as 7 to 10 days before the first SHIV-positive specimen to account for the eclipse period between infection and detection of SHIV RNA in plasma. Infected macaques were monitored for emergence of drug resistance in both plasma and CVF by gauge sequence analysis of SIVmac239 integrase reference sequence groundwork pairs 3624 to 4332 (amino acids 1 to 234). CVF specimens were collected by instilling and recollecting about 5 ml of barren PBS in the vaginal cavity. CVFs were centrifuged for 15 min at 400g to pellet cells and debris. Virion-associated RNA was extracted from CVF supernatant (1 ml) with a Qiagen viral RNA kit. PCR amplification of PBMC proviral DNA was done with primers and probes specific for SIVmac239 pol (6, 34). Serologic testing was performed with a synthetic peptide enzyme immunoassay (Genetic Systems HIV-1/HIV-2 Plus O; Bio-Rad). Animals were considered protected if they tested negative for SHIV RNA in plasma and SHIV DNA in PBMCs and remained seronegative during the challenge period of the study and the 10-week follow-up in the absence of challenge and gel application.Measurement of drug concentrations in plasma
L-812 and RAL levels in plasma were measured in macaques 30 min after vaginal administration of 0.2% L-812 and 1% RAL gel, respectively. Briefly, drug was extracted from 100 μl of plasma by protein precipitation with 350 μl of methanol containing 200 ng of the unstudied analyte as the internal gauge (RAL was used as an internal gauge for L-812 and vice versa). Supernatant containing the drug from precipitation was evaporated to near dryness under vacuum and then resuspended in high-performance liquid chromatography (HPLC) buffer A (9.9 mM acetic acid, 5.9 mM ammonium hydroxide, and 9.4 mM formic acid in H2O). Drug concentrations were analyzed by HPLC–tandem mass spectrometry routine with a Shimadzu Prominence HPLC (Shimadzu Scientific) system equipped with a 150 × 2.0–mm Ascentis Phenyl column (Sigma-Aldrich) and an AB Sciex 3200 QTRAP mass spectrometer. Chromatography was done with a linear gradient of 20 to 90% buffer B (acetonitrile containing 9.9 mM acetic acid, 5.9 mM ammonium hydroxide, and 9.4 mM formic acid). Mass spectrometer was rush in positive MRM (multiple reaction monitoring) mode, and the following transitions were monitored: for RAL, mass/charge ratio (m/z) 445.2/109.0 and 445.2/361.5, and for L-812, m/z 354.1/109.0 and 354.1/203.0. The assay had a lower confine of quantification of 5 ng/ml for both analytes and gauge curve R2 values greater than 0.99.Menstrual cycle and drug absorption monitoring
A longitudinal assessment of drug absorption in relation to menstrual cycle was done by measuring plasma drug and progesterone levels 30 min after vaginal gel application throughout the challenge period for each animal and each cycle. Plasma samples collected twice per week (every 3 to 4 days) were analyzed for drug levels as described above, and progesterone levels were measured at the University of Wisconsin National Primate Research seat with an enzyme immunoassay (37).Statistical methods
Fisher’s exact test was used to compare the number of infections per number of months at risk by study group. Risk for infection per month, or approximately per menstrual cycle, with biweekly challenge doses throughout each month, considers that cycling pigtailed macaques are more susceptible to infection during the luteal aspect of the menstrual cycle as previously demonstrated in this model (23). Intervention efficacy was calculated as 1 − (p1/p0), where p1 and p0 denote the proportion of months with incident infection for intervention and control animals, respectively (38). SAS version 9.2.1 or GraphPad Prism 5 for Windows (GraphPad Software, www.graphpad.com) was used for totality statistical analyses.REFERENCES AND NOTES
The VOICE Study (MTN-003) (2013).
J. Marrazzo, G. Ramjee, G. Nair, T. Palanee, B. Mkhize, C. Nakabiito, M. Taljaard, J. Piper, K. Gomez, M. Chirenje, Pre-exposure prophylaxis for HIV in women: Daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003), paper presented at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 3 to 6 March 2013.
C. Dobard, S. Sharma, repercussion of Depo-Provera and menstrual cycle on vaginal absorption of antiretroviral drugs from gels in pigtail macaques, paper presented at the 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 3 to 6 March 2013.
Good day, CIOs. Estonia’s tech-savvy population has helped transform the country into an innovation hub, with the tiny Baltic nation hitting above its weight in launching startups. Similarly, Estonia’s geographical location has propelled the government’s approach to technology. Estonia is a leader in cybersecurity, but also blockchain and e-citizenship, a digital-first approach to sovereignty that makes sense when Russia is your neighbor. Now Estonia is working toward a national policy concerning artificial intelligence. CIO Journal’s Sara Castellanos talks with Siim Sikkut, Estonia’s chief information officer, about the effort.
A national AI action plan. “We could just tinker around without having a coordinated, coherent plan,” said Mr. Sikkut. “But if you want to execute a concentrated pains and plod stout and fast, you requisite to motif out what to setaside in motion, (what) barriers to break, and that’s what the scheme gives us.” Estonia’s upcoming action scheme will address issues such as the extent to which government should exhaust AI without being overly reliant on the technology or intruding on privacy, Mr. Sikkut said.
A minuscule club. The country, with a population of about 1.3 million, will join several others that occupy developed national strategies to promote the exhaust and progress of AI, including China, Finland, Canada, France and Germany. Guidelines for how to deploy AI, and to what extent, will live faultfinding for governments seeking to maximize their relevance in the unusual global economy, said Keith Strier, EY's global and Americas artificial intelligence leader and the lead partner and senior advisor on the project with Estonia. “Not having a national AI action scheme will addupto a failure to really coordinated focused resources, which, in a smaller country is more essential because there’s more limited resources.”
What happens in Vegas (goes to the cloud). Amazon.com Inc.'s cloud unit unveiled a number of goodies at its annual event in Las Vegas, Among them:
VMware-enabled hardware for hybrid cloud users to exhaust in their own data centers through a service called AWS Outposts. (GeekWire).
Its own server chips, called Graviton, built on the ARM architecture used in smartphone chips. (Wired), and a machine learning chip, Inferentia. (Reuters)
A managed blockchain offering and Amazon Quantum Ledger Database, "where customers can replicate a copy of their blockchain network activity." (CNBC)
A Windows-compatible service targeting potential Azure users. (Bloomberg)
A remote-controlled car that can live trained using re-enforced learning. (Business Insider)
Facebook emails disclose discussion on monetizing user data. Internal emails, most from 2012 to 2104, demonstrate that Facebook Inc. considered charging companies for continued access to user data several years ago. The emails likewise indicate that Facebook employees discussed pushing some advertisers to disburse more in revert for increased access to user information. Writes Journal's Deepa Seetharaman: "Taken together, the internal emails demonstrate the company discussing how to monetize its user data in ways that are employed by some other tech firms but that Facebook has said it doesn’t do."
Amazon makes inroads selling medical supplies to the sick. A growing number of doctors around the U.S. can direct a patient to Amazon.com Inc. for medical products via an app embedded in the patient’s private medical record, the WSJ's Melanie Evans reports. Hospitals inform the goal is to supplant the handwritten shopping lists doctors often hand people. But privacy experts express concern that patients could unwittingly participate personal and potentially sensitive health information with Amazon. Federal health-privacy law, enacted in 1996, was never intended to address patients unwittingly sharing sensitive medical data while shopping online, privacy lawyers say.
Microsoft wins $480 million AR Army contract. Microsoft Corp.will supply prototypes of its augmented reality headsets to the U.S. Army. But these are not your ordinary gaming models. The headsets could comprise night vision, thermal sensing and hearing protection. Ultimately the Army could cessation up purchasing up to 100,000 customized HoloLens devices, Bloomberg says.
North Sea oil blockchain platform goes live. Hopes are Vakt, created in by a consortium that includes oil majors Royal Dutch Shell, BP and Norway’s Equinor, will supplant paperwork associated with finalizing oil deals between the players, Reuters reports. The blockchain platform plans to expand to comprise crude U.S. pipelines in 2019.
Justice indict hackers in Atlanta hack. The Justice Department Wednesday indicted two Iranians for a ransomware assault earlier this year that crippled Atlanta’s government for days, the unusual York Times reports. The men, Faramarz Shahi Savandi and Mohammad Mehdi Shah Mansouri, are credited with creating SamSam, ransomware employed against a number of public agencies over the eventual pair years, including the city of Newark and the Port of San Diego and a number of hospitals.
Dell resets customer passwords. Nearly a week after detecting and stopping an attempt by hackers to hook customer data, Dell Technologies Inc. said Tuesday it would reset passwords for totality of its Dell.com online store customers, Reuters reports.
Musk scraps West LA tunnel. The boring Company, Elon Musk's underground transportation venture, will cease work on its tunnel on LA's west side after encountering resistance from community groups, Reuters said. But its work on a towering speed passenger tunnel between Dodger Stadium and nearby subway stops will continue.
Hello? Is it me you're looking for? As companies compete for workers in the tightest labor market in decades, more employers are rethinking the tried-and-true phone interview, rolling out one-sided, automated exchanges in which applicants give recorded responses to a train of questions. The WSJ's Chip Cutter has more on the latest note of the apocalypse.
Amazon store comes to NYC's SoHo. "Spending time browsing here was among my most dismal shopping experiences in recent memory," the unusual York Times writes. "And that was before a 20-something guy bounded into the store and started screaming: 'Alexa! Alexa! Alexa!'"
EVERYTHING ELSE YOU requisite TO KNOW
Trump administration duties occupy scrambled the global steel trade, with countries that can no longer sell into the U.S. sending their products into Europe at a record rate. (WSJ)
Renault, Nissan and Mitsubishi are “fully committed” to their global auto alliance, as top executives gathered for the first meeting of the partnership since the arrest eventual week of its prime architect, Carlos Ghosn. (WSJ)
Deutsche Bank offices were searched by police and prosecutors seeking evidence in connection with alleged money laundering, the Frankfurt prosecutor’s office said. (WSJ)
Oil prices were hit by another wave of heavy selling, with fears of climbing production dragging the two most accepted benchmarks to lows not seen in more than a year. (WSJ)
3COM [8 Certification Exam(s) ]
AccessData [1 Certification Exam(s) ]
ACFE [1 Certification Exam(s) ]
ACI [3 Certification Exam(s) ]
Acme-Packet [1 Certification Exam(s) ]
ACSM [4 Certification Exam(s) ]
ACT [1 Certification Exam(s) ]
Admission-Tests [13 Certification Exam(s) ]
ADOBE [93 Certification Exam(s) ]
AFP [1 Certification Exam(s) ]
AICPA [2 Certification Exam(s) ]
AIIM [1 Certification Exam(s) ]
Alcatel-Lucent [13 Certification Exam(s) ]
Alfresco [1 Certification Exam(s) ]
Altiris [3 Certification Exam(s) ]
Amazon [2 Certification Exam(s) ]
American-College [2 Certification Exam(s) ]
Android [4 Certification Exam(s) ]
APA [1 Certification Exam(s) ]
APC [2 Certification Exam(s) ]
APICS [2 Certification Exam(s) ]
Apple [69 Certification Exam(s) ]
AppSense [1 Certification Exam(s) ]
APTUSC [1 Certification Exam(s) ]
Arizona-Education [1 Certification Exam(s) ]
ARM [1 Certification Exam(s) ]
Aruba [6 Certification Exam(s) ]
ASIS [2 Certification Exam(s) ]
ASQ [3 Certification Exam(s) ]
ASTQB [8 Certification Exam(s) ]
Autodesk [2 Certification Exam(s) ]
Avaya [101 Certification Exam(s) ]
AXELOS [1 Certification Exam(s) ]
Axis [1 Certification Exam(s) ]
Banking [1 Certification Exam(s) ]
BEA [5 Certification Exam(s) ]
BICSI [2 Certification Exam(s) ]
BlackBerry [17 Certification Exam(s) ]
BlueCoat [2 Certification Exam(s) ]
Brocade [4 Certification Exam(s) ]
Business-Objects [11 Certification Exam(s) ]
Business-Tests [4 Certification Exam(s) ]
CA-Technologies [21 Certification Exam(s) ]
Certification-Board [10 Certification Exam(s) ]
Certiport [3 Certification Exam(s) ]
CheckPoint [43 Certification Exam(s) ]
CIDQ [1 Certification Exam(s) ]
CIPS [4 Certification Exam(s) ]
Cisco [318 Certification Exam(s) ]
Citrix [48 Certification Exam(s) ]
CIW [18 Certification Exam(s) ]
Cloudera [10 Certification Exam(s) ]
Cognos [19 Certification Exam(s) ]
College-Board [2 Certification Exam(s) ]
CompTIA [76 Certification Exam(s) ]
ComputerAssociates [6 Certification Exam(s) ]
Consultant [2 Certification Exam(s) ]
Counselor [4 Certification Exam(s) ]
CPP-Institue [2 Certification Exam(s) ]
CPP-Institute [2 Certification Exam(s) ]
CSP [1 Certification Exam(s) ]
CWNA [1 Certification Exam(s) ]
CWNP [13 Certification Exam(s) ]
CyberArk [1 Certification Exam(s) ]
Dassault [2 Certification Exam(s) ]
DELL [11 Certification Exam(s) ]
DMI [1 Certification Exam(s) ]
DRI [1 Certification Exam(s) ]
ECCouncil [21 Certification Exam(s) ]
ECDL [1 Certification Exam(s) ]
EMC [129 Certification Exam(s) ]
Enterasys [13 Certification Exam(s) ]
Ericsson [5 Certification Exam(s) ]
ESPA [1 Certification Exam(s) ]
Esri [2 Certification Exam(s) ]
ExamExpress [15 Certification Exam(s) ]
Exin [40 Certification Exam(s) ]
ExtremeNetworks [3 Certification Exam(s) ]
F5-Networks [20 Certification Exam(s) ]
FCTC [2 Certification Exam(s) ]
Filemaker [9 Certification Exam(s) ]
Financial [36 Certification Exam(s) ]
Food [4 Certification Exam(s) ]
Fortinet [13 Certification Exam(s) ]
Foundry [6 Certification Exam(s) ]
FSMTB [1 Certification Exam(s) ]
Fujitsu [2 Certification Exam(s) ]
GAQM [9 Certification Exam(s) ]
Genesys [4 Certification Exam(s) ]
GIAC [15 Certification Exam(s) ]
Google [4 Certification Exam(s) ]
GuidanceSoftware [2 Certification Exam(s) ]
H3C [1 Certification Exam(s) ]
HDI [9 Certification Exam(s) ]
Healthcare [3 Certification Exam(s) ]
HIPAA [2 Certification Exam(s) ]
Hitachi [30 Certification Exam(s) ]
Hortonworks [4 Certification Exam(s) ]
Hospitality [2 Certification Exam(s) ]
HP [752 Certification Exam(s) ]
HR [4 Certification Exam(s) ]
HRCI [1 Certification Exam(s) ]
Huawei [21 Certification Exam(s) ]
Hyperion [10 Certification Exam(s) ]
IAAP [1 Certification Exam(s) ]
IAHCSMM [1 Certification Exam(s) ]
IBM [1533 Certification Exam(s) ]
IBQH [1 Certification Exam(s) ]
ICAI [1 Certification Exam(s) ]
ICDL [6 Certification Exam(s) ]
IEEE [1 Certification Exam(s) ]
IELTS [1 Certification Exam(s) ]
IFPUG [1 Certification Exam(s) ]
IIA [3 Certification Exam(s) ]
IIBA [2 Certification Exam(s) ]
IISFA [1 Certification Exam(s) ]
Intel [2 Certification Exam(s) ]
IQN [1 Certification Exam(s) ]
IRS [1 Certification Exam(s) ]
ISA [1 Certification Exam(s) ]
ISACA [4 Certification Exam(s) ]
ISC2 [6 Certification Exam(s) ]
ISEB [24 Certification Exam(s) ]
Isilon [4 Certification Exam(s) ]
ISM [6 Certification Exam(s) ]
iSQI [7 Certification Exam(s) ]
ITEC [1 Certification Exam(s) ]
Juniper [65 Certification Exam(s) ]
LEED [1 Certification Exam(s) ]
Legato [5 Certification Exam(s) ]
Liferay [1 Certification Exam(s) ]
Logical-Operations [1 Certification Exam(s) ]
Lotus [66 Certification Exam(s) ]
LPI [24 Certification Exam(s) ]
LSI [3 Certification Exam(s) ]
Magento [3 Certification Exam(s) ]
Maintenance [2 Certification Exam(s) ]
McAfee [8 Certification Exam(s) ]
McData [3 Certification Exam(s) ]
Medical [69 Certification Exam(s) ]
Microsoft [375 Certification Exam(s) ]
Mile2 [3 Certification Exam(s) ]
Military [1 Certification Exam(s) ]
Misc [1 Certification Exam(s) ]
Motorola [7 Certification Exam(s) ]
mySQL [4 Certification Exam(s) ]
NBSTSA [1 Certification Exam(s) ]
NCEES [2 Certification Exam(s) ]
NCIDQ [1 Certification Exam(s) ]
NCLEX [2 Certification Exam(s) ]
Network-General [12 Certification Exam(s) ]
NetworkAppliance [39 Certification Exam(s) ]
NI [1 Certification Exam(s) ]
NIELIT [1 Certification Exam(s) ]
Nokia [6 Certification Exam(s) ]
Nortel [130 Certification Exam(s) ]
Novell [37 Certification Exam(s) ]
OMG [10 Certification Exam(s) ]
Oracle [282 Certification Exam(s) ]
P&C [2 Certification Exam(s) ]
Palo-Alto [4 Certification Exam(s) ]
PARCC [1 Certification Exam(s) ]
PayPal [1 Certification Exam(s) ]
Pegasystems [12 Certification Exam(s) ]
PEOPLECERT [4 Certification Exam(s) ]
PMI [15 Certification Exam(s) ]
Polycom [2 Certification Exam(s) ]
PostgreSQL-CE [1 Certification Exam(s) ]
Prince2 [6 Certification Exam(s) ]
PRMIA [1 Certification Exam(s) ]
PsychCorp [1 Certification Exam(s) ]
PTCB [2 Certification Exam(s) ]
QAI [1 Certification Exam(s) ]
QlikView [1 Certification Exam(s) ]
Quality-Assurance [7 Certification Exam(s) ]
RACC [1 Certification Exam(s) ]
Real-Estate [1 Certification Exam(s) ]
RedHat [8 Certification Exam(s) ]
RES [5 Certification Exam(s) ]
Riverbed [8 Certification Exam(s) ]
RSA [15 Certification Exam(s) ]
Sair [8 Certification Exam(s) ]
Salesforce [5 Certification Exam(s) ]
SANS [1 Certification Exam(s) ]
SAP [98 Certification Exam(s) ]
SASInstitute [15 Certification Exam(s) ]
SAT [1 Certification Exam(s) ]
SCO [10 Certification Exam(s) ]
SCP [6 Certification Exam(s) ]
SDI [3 Certification Exam(s) ]
See-Beyond [1 Certification Exam(s) ]
Siemens [1 Certification Exam(s) ]
Snia [7 Certification Exam(s) ]
SOA [15 Certification Exam(s) ]
Social-Work-Board [4 Certification Exam(s) ]
SpringSource [1 Certification Exam(s) ]
SUN [63 Certification Exam(s) ]
SUSE [1 Certification Exam(s) ]
Sybase [17 Certification Exam(s) ]
Symantec [135 Certification Exam(s) ]
Teacher-Certification [4 Certification Exam(s) ]
The-Open-Group [8 Certification Exam(s) ]
TIA [3 Certification Exam(s) ]
Tibco [18 Certification Exam(s) ]
Trainers [3 Certification Exam(s) ]
Trend [1 Certification Exam(s) ]
TruSecure [1 Certification Exam(s) ]
USMLE [1 Certification Exam(s) ]
VCE [6 Certification Exam(s) ]
Veeam [2 Certification Exam(s) ]
Veritas [33 Certification Exam(s) ]
Vmware [58 Certification Exam(s) ]
Wonderlic [2 Certification Exam(s) ]
Worldatwork [2 Certification Exam(s) ]
XML-Master [3 Certification Exam(s) ]
Zend [6 Certification Exam(s) ]
Dropmark : http://killexams.dropmark.com/367904/11587775
Wordpress : http://wp.me/p7SJ6L-VM
Issu : https://issuu.com/trutrainers/docs/250-323
Dropmark-Text : http://killexams.dropmark.com/367904/12129117
Blogspot : http://killexamsbraindump.blogspot.com/2017/11/just-memorize-these-250-323-questions.html
RSS Feed : http://feeds.feedburner.com/WhereCanIGetHelpToPass250-323Exam
weSRCH : https://www.wesrch.com/business/prpdfBU1HWO000QYAG
publitas.com : https://view.publitas.com/trutrainers-inc/exactly-same-250-323-questions-as-in-real-test-wtf
Calameo : http://en.calameo.com/books/00492352673839f65e3ef
Box.net : https://app.box.com/s/wq3hankli10g7d4lf7rm6hde76rl814b
zoho.com : https://docs.zoho.com/file/5ptno47a2e25a0cc74fe6b1e7f8ba802b1579